Cervical Cancer: 5.73% of Women are in high risk group, says Roche Diagnostics & Adyar Cancer Institute Survey
Adyar Institute Unveils Impact of HPV molecular testing in cervical cancer community screening program in South India Chennai, July 03, 2023: Dr. Vijayalakshmi Ramshankar, Department of Preventive Oncology (Research), Cancer Institute (WIA ), today unveiled research titled “Impact of HPV molecular testing with partial genotyping as a feasibility study in cervical cancer community screening program in South India” in a panel discussion held at Adyar Institute. Dr. Vijayalakshmi and her team that included Ms Soundharya Ravindran; Ms. Komathi Arun, Ms. Kanchana Albert, Ms. Sakthi Lalitha Sri, Dr. Lalitha Ramasubramanian and Dr. Banumathy Satyaseelan have conducted a study involving a group of 10,395 women who were administered the HPV DNA test. Press meet youtube video link ЁЯСЗ ЁЯСЗ The study showed that there is a need for implementation of a high throughput technology for cervical cancer that can be scalable. They used the Cobas 4800, a multiplexed assay based on q...